USP 1207 and the Future of CCI Testing

(6:8)

Trends in USP 1207 CCIT: Complexity of Products and Package Systems

(1:35)

USP 1207 Container Closure Integrity Testing

(4:45)

Trends in USP 1207 CCIT: Validation of a CCI Method

(1:51)

An in-depth discussion on the challenges to USP 1207 CCI Testing for IV Bags.

(9:12)

USP 1207 Helium Leak Testing

(4:8)

Using the USP 1207 Tools to Develop a Comprehensive CCI Profile

(5:)

An Overview of USP 1207: A Guidance Chapter

(55)

USP 1207 and ASTM F2338-09: do they define an allowable leak size? Interview with Serena Santi (BE)

(2:41)

Trends in USP 1207 CCIT: When to Consider CCI

(1:33)

Container Closure Integrity Testing (CCIT) for Pharmaceutical Sterile Barrier Packaging

(1:1:31)

Minor Chapters, Major Impacts: What USP 51, 61 and 1207 Mean for Your Practice

(1:36)

CONTAINER CLOSURE INTEGRITY TESTING | PACKAGING AND LABELING | B.PHARM

(18:53)

Minor Chapters Major Impacts: What USP 51, 61 and 1207 Mean for Your Practice

(58:54)

Tools and Considerations for Developing the Package Integrity Profile

(3:46)

Present and Future Changes to Packaging Industry Standards

(32:29)

Container-Closure Integrity Testing for Drug Delivery Devices

(33:57)

Container Closure Integrity and Stability Testing for Rigid Containers

(52:34)

Implementing New Packaging Integrity Testing Guidelines

(49:25)

Guidance for Understanding Container Closure Integrity Test Failures

(54:33)